Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
VCYT is priced at $47.67 right now, up 4.06% on the session. That puts its market value at $3.83B, 2298th largest among the 3132 stocks we cover.
The stock's 52-week band runs $29.46 to $60.91, and the latest print sits 21.7% under the top end of it. Holders are ahead 32.3% over twelve months, but down 15.1% across the last three months.
On the chart it holds above both the 50-day ($44.77) and 200-day ($42.53) moving averages; RSI is 59, and the last 30 sessions moved at roughly 61% annualized volatility.
For the quarter ended Jun 2026 it reported $150.32M in revenue, up 15.5% from a year earlier, with $25.49M of net profit (a 17.0% margin).
The stock changes hands at 34.1 times trailing earnings. The median for its industry group is 40.6.
11 analysts follow the stock and the average call is "buy". The mean target, $59.78, sits 25.4% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 3 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Trading closer to its 52-week high than most peers scores higher.
11 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
VCYT is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $59.78, 25.4% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $45.81, so shares trade 4.1% above that estimate. On earnings multiple, it sits in the 71st percentile of its own five-year valuation range (pricier than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | +10.0% | Bullish |
| Price vs 50-day average | +6.5% | Bullish |
| Price vs 200-day average | +12.1% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 58.6 | Bullish |
| MACD (12,26,9) | 0.56 | Bullish |
| Bollinger band position | 89% | Bullish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Oct 6, 2026 1:30 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 34.1x earnings, VCYT looks expensive against the market, and trades 16% below the 40.6x median among Diagnostics & Research names. The two comparisons do not always agree.
$47.67 is the latest print for VCYT, a move of +4.06% against yesterday's close of $45.81. Today's low and high so far: $45.00 and $47.79.
Equity value comes to $3.83B at the current price. By that measure it is number 2298 of the 3132 names in our coverage.
Buyers pay 34.1 times the last twelve months of profit (EPS $0.82).
The year's floor is $29.46 and the ceiling $60.91. Shares are 21.7% away from that ceiling.
Our data shows no dividend paid by Veracyte over the trailing twelve months.
Of 11 analysts, 82% say buy, 9% hold and 9% sell. Price targets average $59.78, with the most cautious at $44.00 and the most optimistic at $70.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on VCYT.